Course Objectives:
- To differentiate the various working principles of optical imaging systems
- To outline the various applications of biosensors in medicine
- To analyse the working principle of flow cytometer
- To describe the importance of photodynamic therapy in treatment of diseases
- To explain about Bionanophotonics and other advance topics
Course Outcomes:
After completing this course, students should be able to
CO1: Integrate their understanding of biophotonics with fundamental principles of light and matter, demonstrating a profound comprehension of the interdisciplinary nature of this field.
CO2: Apply advanced laser technology and nonlinear optics in the context of biophotonics, including the quantitative description of light, radiometry, time-resolved studies, and laser safety protocols.
CO3: Demonstrate principles and techniques of bioimaging, encompassing various microscopy methods, optical coherence tomography, spectral and time-resolved imaging, and related technologies for applications in the biomedical domain.
CO4: Demonstrate expertise in the application of biosensors, flow cytometry, and photodynamic therapy, with a nuanced understanding of microarray technology for genomics and proteomics, basic principles of flow cytometry, and the fundamental aspects of photodynamic therapy.
CO5: Gain insights into emerging areas such as bionanophotonics, array technologies, optical diagnostics, targeted therapy, super-resolution microscopy techniques, ultrasound-mediated biophotonics imaging, and the application of deep learning in biophotonics through relevant case studies.
CO-PO Mapping
PO/P
SO |
PO1 |
PO2 |
PO3 |
PO4 |
PO5 |
PO 6 |
PO7 |
PO8 |
PO 9 |
PO 10 |
PO 11 |
PO 12 |
PSO 1 |
PSO2 |
PSO3 |
CO |
CO1 |
3 |
– |
– |
– |
– |
– |
– |
– |
2 |
2 |
– |
2 |
1 |
2 |
– |
CO2 |
– |
1 |
2 |
1 |
– |
2 |
– |
– |
2 |
2 |
– |
2 |
2 |
2 |
1 |
CO3 |
– |
1 |
3 |
3 |
– |
– |
– |
– |
2 |
2 |
– |
2 |
2 |
2 |
– |
CO4 |
– |
1 |
2 |
– |
– |
– |
1 |
1 |
2 |
2 |
– |
2 |
2 |
1 |
– |
CO5 |
– |
– |
– |
– |
– |
2 |
3 |
2 |
2 |
– |
2 |
2 |
– |
– |